SCHEMBL15870557

SCHEMBL15870557

NC(=O)c1ccc(-c2cncc(N[C@@H](CO)c3ccccc3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK8 P49336 2/20 0.59
▸ CCNC P24863 1/20 0.59
▸ MKNK2 Q9HBH9 7/20 0.58
▸ MKNK1 Q9BUB5 7/20 0.58
▸ ROCK1 Q13464 6/20 0.52
▸ ROCK2 O75116 5/20 0.52
▸ GSK3B P49841 4/20 0.52
▸ CLK4 Q9HAZ1 4/20 0.52
▸ CDK2 P24941 3/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ MAP4K4 O95819 3/20 0.52
▸ RPS6KA5 O75582 3/20 0.52
▸ AKT1 P31749 3/20 0.52
▸ NEK4 P51957 3/20 0.52
▸ PRKCD Q05655 3/20 0.52
▸ PRKG2 Q13237 3/20 0.52
▸ PRKG1 Q13976 3/20 0.52
▸ PKN2 Q16513 3/20 0.52
▸ GSK3A P49840 3/20 0.52
▸ MAPK13 O15264 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15870566 0.91 CDK8 (0.61) CDK8CCNCMKNK2MKNK1ROCK1
SCHEMBL15870581 0.86 CDK8 (0.57) CDK8CCNCROCK1ROCK2GSK3B
SCHEMBL15870530 0.84 CCNC (0.58) CDK8CCNCMKNK2MKNK1ROCK1
SCHEMBL15870508 0.83 CCNC (0.64) CDK8CCNCROCK1ROCK2GSK3B
SCHEMBL15870515 0.83 CCNC (0.64) CDK8CCNCMKNK2MKNK1ROCK1
SCHEMBL15870552 0.83 CCNC (0.64) CDK8CCNCROCK1ROCK2GSK3B
SCHEMBL15870506 0.83 CCNC (0.64) CDK8CCNCROCK1ROCK2GSK3B
SCHEMBL15870532 0.80 CCNC (0.63) CDK8CCNCROCK1ROCK2CDK2
SCHEMBL15870567 0.80 CCNC (0.60) CDK8CCNCROCK1ROCK2GSK3B
SCHEMBL15870509 0.80 CCNC (0.60) CDK8CCNCROCK1ROCK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 — — WO disclosed
Send feedback